Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

Phase 1/2a Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors

Phase 1/2a Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors
Conditions:   Solid Tumor, Adult;   Soft Tissue Sarcoma;   Non Small Cell Lung Cancer;   Small Cell Lung Cancer
Interventions:   Drug: Part 1: AL3818;   Drug: Part 1: Nivolumab Injection;   Drug: Part 2: AL3818;   Drug: Part 2: Nivolumab Injection
Sponsors:   Sarcoma Oncology Research Center, LLC;   Advenchen Laboratories, LLC
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 16, 2019 / by / in
Comments